Engineers Gate Manager LP Ligand Pharmaceuticals Inc Transaction History

Engineers Gate Manager LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$69.53 - $79.33 $117,783 - $134,385	-1,694 Reduced 35.32%	3,102 $223,000
Q1 2023 May 15, 2023	SELL	$65.67 - $77.08 $627,476 - $736,499	-9,555 Reduced 66.58%	4,796 $352,000
Q4 2022 Feb 14, 2023	BUY	$61.72 - $96.74 $729,160 - $1.14 Million	11,814 Added 465.67%	14,351 $958,000
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $25 - $272,879	2,537 New	2,537 $218,000
Q1 2021 May 17, 2021	SELL	$99.52 - $215.83 $2.05 Million - $4.44 Million	-20,584 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$80.55 - $106.05 $214,343 - $282,199	-2,661 Reduced 11.45%	20,584 $2.05 Million
Q3 2020 Nov 16, 2020	BUY	$89.56 - $126.72 $1.74 Million - $2.46 Million	19,436 Added 510.27%	23,245 $2.22 Million
Q2 2020 Aug 17, 2020	SELL	$68.28 - $123.65 $131,097 - $237,408	-1,920 Reduced 33.51%	3,809 $426,000
Q1 2020 May 15, 2020	BUY	$63.37 - $107.88 $58,617 - $99,789	925 Added 19.25%	5,729 $417,000
Q4 2019 Feb 14, 2020	BUY	$96.94 - $113.59 $465,699 - $545,686	4,804 New	4,804 $501,000
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $644,280 - $776,040	-6,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$105.93 - $142.47 $2.16 Million - $2.91 Million	-20,416 Reduced 77.29%	6,000 $754,000
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $20,152 - $42,724	157 Added 0.6%	26,416 $3.59 Million
Q3 2018 Nov 01, 2018	BUY	$211.18 - $274.49 $5.55 Million - $7.21 Million	26,259 New	26,259 $7.21 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.